Adjuvant and salvage radiotherapy after radical prostatectomy in prostate cancer patients
G Gandaglia, A Briganti, N Clarke, RJ Karnes… - European urology, 2017 - Elsevier
Abstract Context Prostate cancer (PCa) patients found to have adverse pathologic features
following radical prostatectomy (RP) are less likely to be cured with surgery alone. Objective …
following radical prostatectomy (RP) are less likely to be cured with surgery alone. Objective …
Stereotactic radiotherapy after radical prostatectomy in patients with prostate cancer in the adjuvant or salvage setting: a systematic review
C Schroeder, H Tang, P Windisch, DR Zwahlen… - Cancers, 2022 - mdpi.com
Simple Summary Stereotactic body radiotherapy, a type of high-precision radiotherapy
delivering high doses within few treatment sessions has proven to be effective and well …
delivering high doses within few treatment sessions has proven to be effective and well …
PSMA PET/CT with Glu-urea-Lys-(Ahx)-[68Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer
FL Giesel, H Fiedler, M Stefanova, F Sterzing… - European journal of …, 2015 - Springer
Purpose PET/CT with the PSMA ligand is a powerful new method for the early detection of
nodal metastases in patients with biochemical relapse. The purpose of this retrospective …
nodal metastases in patients with biochemical relapse. The purpose of this retrospective …
Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part I: introduction and treatment decision-making at the time of suspected biochemical recurrence …
TM Morgan, SA Boorjian, MK Buyyounouski… - Journal of …, 2024 - journals.lww.com
Purpose: The summary presented herein covers recommendations on salvage therapy for
recurrent prostate cancer intended to facilitate care decisions and aid clinicians in caring for …
recurrent prostate cancer intended to facilitate care decisions and aid clinicians in caring for …
[PDF][PDF] 68Ga-PSMA PET/CT for the evaluation of metastasis in patients with prostate cancer: a systematic review and meta-analysis
J Zhou, R Wu, W Wang, Y Zhao, X Liu - Hell J Nucl Med, 2022 - nuclmed.gr
Objective: The aim of this study was to assess the diagnostic value of gallium-68-prostate
specific membra-8 ne antigen (6 Ga-PSMA) positron emission tomography/computed …
specific membra-8 ne antigen (6 Ga-PSMA) positron emission tomography/computed …
Prostate cancer: utility of whole-lesion apparent diffusion coefficient metrics for prediction of biochemical recurrence after radical prostatectomy
AB Rosenkrantz, JM Ream, P Nolan… - American Journal of …, 2015 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study was to investigate the additional value of whole-
lesion histogram apparent diffusion coefficient (ADC) metrics, when combined with standard …
lesion histogram apparent diffusion coefficient (ADC) metrics, when combined with standard …
Disease control with delayed salvage radiotherapy for macroscopic local recurrence following radical prostatectomy
M Shelan, S Odermatt, B Bojaxhiu, DP Nguyen… - Frontiers in …, 2019 - frontiersin.org
Purpose: To retrospectively assess clinical outcomes and toxicity profile of prostate cancer
patients treated with delayed dose-escalated image-guided salvage radiotherapy (SRT) for …
patients treated with delayed dose-escalated image-guided salvage radiotherapy (SRT) for …
Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial?
S Taguchi, K Shiraishi, H Fukuhara, K Nakagawa… - Radiation …, 2016 - Springer
Background The optimal timing of salvage radiotherapy for biochemical recurrence after
radical prostatectomy is controversial. In particular, the prognostic significance of salvage …
radical prostatectomy is controversial. In particular, the prognostic significance of salvage …
Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After …
L Ah-Thiane, L Campion, N Allouache, E Meyer… - European Urology …, 2024 - Elsevier
Background The relevance of next-generation hormone therapies and circulating tumor cells
(CTCs) are not elucidated in biochemical recurrence after prostatectomy. Objective To …
(CTCs) are not elucidated in biochemical recurrence after prostatectomy. Objective To …
Optimizing the timing of salvage postprostatectomy radiotherapy and the use of concurrent hormonal therapy for prostate cancer
Context Currently, salvage radiotherapy (SRT) is the only known curative intervention for
men with recurrent disease following prostatectomy. Critical issues in the optimal selection …
men with recurrent disease following prostatectomy. Critical issues in the optimal selection …